Cell-based bone reconstruction therapies - Cell sources

International Journal of Oral and Maxillofacial Implants

Volumn 21, Issue 6, 2006, Pages 890-898

  Handschel, Jörg ^a   Wiesmann, Hans Peter ^b   Depprich, Rita ^a   Kübier, Norbert R ^a   Meyer, Ulrich ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Bone tissue engineering; Cell sources; Differentiation capacity

Indexed keywords

ARTICLE; BONE; CELL LINE; CULTURE TECHNIQUE; CYTOLOGY; HUMAN; METHODOLOGY; PHYSIOLOGY; PLASTIC SURGERY; STEM CELL; TISSUE ENGINEERING;

BONE AND BONES; CELL CULTURE TECHNIQUES; CELL LINE; HUMANS; RECONSTRUCTIVE SURGICAL PROCEDURES; STEM CELLS; TISSUE ENGINEERING;

EID: 33846324440     PISSN: 08822786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. Binderman I, Fin N. Bone substitutes organic, inorganic, and polymeric: Cell material interactions. In: Yamamuro T, Hench L, Wilson J (eds). CRC Handbook of Bioactive Ceramics. Boca Raton, FL: CRC Press, 1990:45-51.
2. Damien CJ, Parsons JR. Bone graft and bone graft substitutes: A review of current technology and applications. J Appl Biomater 1991;2:187-208.
3. Langer R, Vacanti JP. Tissue engineering. Science 1993;260:920-926.
4. Lysaght MJ, Reyes J. The growth of tissue engineering. Tissue Eng 2001;7:485-493.
5. Mooney DJ, Boontheekul T, Chen R, Leach K. Actively regulating bioengineered tissue and organ formation. Orthod Craniofac Res 2005;8:141-144.
6. Drury JL, Mooney DJ. Hydrogels for tissue engineering: Scaffold design variables and applications. Biomaterials 2003;24:4337-4351.
7. Meyer U, Joos U, Wiesmann HP. Biological and biophysical principles in extracorporal bone tissue engineering. Part I. Int J Oral Maxillofac Surg 2004;33:325-332.
8. Meyer U, Joos U, Wiesmann HP. Biological and biophysical principles in extracorporal bone tissue engineering. Part III. Int J Oral Maxillofac Surg 2004;33:635-641.
9. Meyer U, Wiesmann HP, Berr K, Kübler NR, Handschel J. Cell-based bone reconstruction therapies-Principles of clinical approaches, Int J Oral Maxillofac Implants 2006;21:901-908.
10. Yamaguchi M, Hirayama F, Murahashi H, et al. Ex vivo expansion of human UC blood primitive hematopoietic progenitors and transplantable stem cells using human primary BM stromal cells and human AB serum. Cytotherapy 2002;4(2):109-118.
11. Heng BC, Cao T, Stanton LW, Robson P, Olsen B. Strategies for directing the differentiation of stem cells into the osteogenic lineage in vitro. J Bone Miner Res 2004;19:1379-1394.
12. zur Nieden NI, Kempka G, Rancourt DE, Ahr HJ. Induction of chondro-, osteo- and adipogenesis in embryonic stem cells by bone morphogenetic protein-2: Effect of cofactors on differentiating lineages. BMC Dev Biol 2005;5(1):1.
13. Kogler G, Sensken S, Airey JA, et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 2004;200:123-135.
14. Ashton BA, Allen TD, Howlett CR, Eaglesom CC, Hattori A, Owen M, Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo. Clin Orthop Relat Res 1980:294-307.
15. Halleux C, Sottile V, Gasser JA, Seuwen K. Multi-lineage potential of human mesenchymal stem cells following clonal expansion. J Musculoskelet Neuronal Interact 2001;2(1):71-76.
16. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
17. Moosmann S, Mutter J, Moser C, Krombach F, Huss R. Milieuadopted in vitro and in vivo differentiation of mesenchymal tissues derived from different adult human CD34-negative progenitor cell clones. Cells Tissues Organs 2005;179:91-101.
18. Guilak F, Lott KE, Awad HA, et al. Clonal analysis of the differentiation potential of human adipose-derived adult stem cells. J Cell Physiol 2006;206(1):229-237.
19. Covas DT, Piccinato CE, Orellana MD, et al. Mesenchymal stem cells can be obtained from the human saphena vein. Exp Cell Res 2005;309:340-344.
20. In't Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 2004;22:1338-1345.
21. Wulf GG, Viereck V, Hemmerlein B, et al. Mesengenic progenitor cells derived from human placenta.Tissue Eng 2004;10:1136-1147.
22. Seo BM, Miura M, Gronthos S, et al. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 2004;364:149-155.
23. Ng AM, Saim AB, Tan KK, et al. Comparison of bioengineered human bone construct from four sources of osteogenic cells. J Orthop Sci 2005;10(2):192-199.
24. Sakaguchi Y, Sekiya I, Yagishita K, Ichinose S, Shinomiya K, Muneta T. Suspended cells from trabecular bone by collagenase digestion become virtually identical to mesenchymal stem cells obtained from marrow aspirates. Blood 2004;104:2728-2735.
25. Hattori H, Sato M, Masuoka K, et al. Osteogenic potential of human adipose tissue-derived stromal cells as an alternative stem cell source. Cells Tissues Organs 2004;178:2-12.
26. Zuk PA, Zhu M, Ashjian R et al. Human adipose tissue is a source of multipotential stem cells. Mol Biol Cell 2002;13:4279-4295.
27. Lee RH, Kim B, Choi I, et al. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 2004;14(46)311-324.
28. Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 2000;113:1161-1166.
29. Safford KM, Hicok KC, Safford SD, et al. Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochem Biophys Res Commun 2002;294:371-379.
30. Tondreau T, Lagneaux L, Dejeneffe M, et al. Bone marrow-derived mesenchymal stem cells already express specific neural proteins before any differentiation. Differentiation 2004;72:319-326.
31. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 1981;78:7634-7638.
32. Bielby RC, Boccaccini AR, Polak JM, Buttery LD. In vitro differentiation and in vivo mineralization of osteogenic cells derived from human embryonic stem cells. Tissue Eng 2004;10:1518-1525.
33. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981;292:154-156.
34. Burt RK, Verda L, Kim DA, Oyama Y, Luo K, Link C. Embryonic stem cells as an alternate marrow donor source: Engraftment without graft-versus-host disease. J Exp Med 2004;199:895-904.
35. Chambers I. The molecular basis of pluripotency in mouse embryonic stem cells. Cloning Stem Cells 2004;6:386-391.
36. Smith AG, Heath JK, Donaldson DD, et al. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 1988;336:688-690.
37. Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000;24:372-376.
38. Klug MG, Soonpaa MH, Koh GY, Field U. Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J Clin Invest 1996;98:216-224.
39. Lee SH, Lumelsky N, Studer L, Auerbach JM, McKay RD. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol 2000;18:675-679.
40. McDonald JW, Liu XZ, Qu Y, et al. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med 1999;5:1410-1412.
41. Drab M, Haller H, Bychkov R, et al. From totipotent embryonic stem cells to spontaneously contracting smooth muscle cells: A retinoic acid and db-cAMP in vitro differentiation model. Faseb J 1997;11:905-915.
42. Chaudhry GR Yao D, Smith A, Hussain A. Osteogenic cells derived from embryonic stem cells produced bone nodules in three-dimensional scaffolds. J Biomed Biotechnol 2004;2004(4):203-210.
43. D'lppolito G, Schiller PC, Ricordi C, Roos BA, Howard GA. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res 1999;14:1115-1122.
44. Quarto R, Thomas D, Liang CT. Bone progenitor cell deficits and the age-associated decline in bone repair capacity. Calcif Tissue Int 1995;56(2):123-129.
45. Zavazava N. Embryonic stem cells and potency to induce transplantation tolerance. Expert Opin Biol Ther 2003;3:5-13.
46. Trounson A. Human embryonic stem cells: Mother of all cell and tissue types. Reprod Biomed Online 2002;4(suppl 1):58-63.
47. Cogle CR, Guthrie SM, Sanders RC, Allen WL, Scott EW,Petersen BE. An overview of stem cell research and regulatory issues. Mayo Clin Proc 2003;78:993-1003.
48. Gilbert DM. The future of human embryonic stem cell research: addressing ethical conflict with responsible scientific research. Med Sci Monit 2004;10:RA99-RA103.
49. Caplan AI. Mesenchymal stem cells. J Orthop Res 1991;9:641-650.
50. Kale S, Long MW. Osteopoiesis: The early development of bone cells. Crit Rev Eukaryot Gene Expr 2000;10:259-271.
51. Aubin JE, Liu F. The osteoblast lineage. In: Bilezikian J, Raisz L, Rodan G (eds). Principles of Bone Biology. San Diego: Academic Press, 1996:51-67.
52. Egrise D, Martin D, Vienne A, Neve P, Schoutens A.The number of fibroblastic colonies formed from bone marrow is decreased and the in vitro proliferation rate of trabecular bone cells increased in aged rats. Bone 1992;13:355-361.
53. Panepucci RA, Siufi JL, Silva WA Jr, et al. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells 2004;22:1263-1278.
54. Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A 1999;96:10711-10716.
55. Shimko DA, Burks CA, Dee KC, Nauman EA. Comparison of in vitro mineralization by murine embryonic and adult stem cells cultured in an osteogenic medium.Tissue Eng 2004;10:1386-1398.
56. Mauney JR, Jaquiery C, Volloch V, Heberer M, Martin I, Kaplan DL. In vitro and in vivo evaluation of differentially demineralized cancellous bone scaffolds combined with human bone marrow stromal cells for tissue engineering. Biomaterials 2005:26:3173-3185.
57. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies.Tissue Eng 2001;7:211-228.
58. Hicok KC, Du Laney TV, Zhou YS, et al. Human adipose-derived adult stem cells produce osteoid in vivo. Tissue Eng 2004;10:371-380.
59. Schantz JT, Hutmacher DW, Chim H, Ng KW, Lim T, Jeoh SH. Induction of ectopic bone formation by using human periosteal cells in combination with a novel scaffold technology. Cell Transplant 2002;11:125-138.
60. Schantz JT, Hutmacher DW, Ng KW, Khor HL, Lim MT, Teoh SH. Evaluation of a tissue-engineered membrane-cell construct for guided bone regeneration. Int J Oral Maxillofac Implants 2002;17:161-174.
61. Meyer U, Wiesmann HP. Bone and Cartilage Tissue Engineering. Berlin: Springer, 2005.
62. Hutmacher DW, Sittinger M. Periosteal cells in bone tissue engineering. Tissue Eng 2003;9(suppl 1):S45-S64.
63. Vacanti CA, Kim W, Upton J, et al. Tissue-engineered growth of bone and cartilage. Transplant Proc 1993;25(1 Pt 2):1019-1021.
64. Aubin JE. Regulation of osteoblast formation and function. Rev Endocr Metab Disord 2001;2(1):81-94.
65. Dempster DW, Cosman F, Parisien M, Shen V, Lindsay R. Anabolic actions of parathyroid hormone on bone. Endocr Rev 1993;14:690-709.
66. Lian JB, Stein GS, Stein JL, van Wijnen AJ. Regulated expression of the bone-specific osteocalcin gene by vitamins and hormones. Vitam Horm 1999:55:443-509.
67. Turner RT, Riggs BL, Spelsberg TC. Skeletal effects of estrogen. Endocr Rev 1994;15:275-300.
68. Boyce BF, Hughes DE, Wright KR, Xing L, Dai A. Recent advances in bone biology provide insight into the pathogenesis of bone diseases. Lab Invest 1999;79:83-94.
69. Delany AM, Dong Y, Canalis E. Mechanisms of glucocorticoid action in bone cells. J Cell Biochem 1994;56:295-302.
70. Ishida Y, Heersche JN. Glucocorticoid-induced osteoporosis: both in vivo and in vitro concentrations of glucocorticoids higher than physiological levels attenuate osteoblast differentiation. J Bone Miner Res 1998;13:1822-1826.
71. Parfitt AM. The cellular basis of bone turnover and bone loss: A rebuttal of the osteocytic résorption-Bone flow theory. Clin Orthop Relat Res 1977;(127):236-247.
72. Jones DB, Nolte H, Scholubbers JG, Turner E, Veltel D. Biochemical signal transduction of mechanical strain in osteoblast-like cells. Biomaterials 1991;12:101-110.
73. Wada Y, Kataoka H, Yokose S, et al. Changes in osteoblast phenotype during differentiation of enzymatically isolated rat calvaria cells. Bone 1998:22:479-485.
74. Elgendy HM, Norman ME, Keaton AR, Laurencin CT. Osteoblast-like cell (MC3T3-E1) proliferation on bioerodible polymers: An approach towards the development of a bone-bioerodible polymer composite material. Biomaterials 1993;14:263-269.
75. Aubin JE. Advances in the osteoblast lineage. Biochem Cell Biol 1998;76:899-910.
76. Xiaoxue Y, Zhongqiang C, Zhaoqing G, Gengting D, Qingjun M, Shenwu W. Immortalization of human osteoblasts by transferring human telomerase reverse transcriptase gene. Biochem Biophys Res Commun 2004;315:643-651.
77. Franceschi RT. Biological approaches to bone regeneration by gene therapy. J Dent Res 2005;84:1093-1103.
78. Franceschi RT, Yang S, Rutherford RB, Krebsbach PH, Zhao M, Wang D.Gene therapy approaches for bone regeneration. Cells Tissues Organs 2004;176:95-108.
79. Owen TA, Aronow M, Shalhoub V, et al. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 1990;143:420-430.